Kang-Yell Choi

USPTO Granted Patents = 12 (Patent Applications = 8)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

Amorepacific Corporation

patents

Years Active: 2015-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12303490 - Compositions and methods for suppressing and/or treating neurodegenerative diseases and/or a clinical condition thereof (2025-05-20),

2. 11773081 - Pharmaceutical composition for preventing or treating wound, comprising indirubin derivative as active ingredient (2023-10-03),

3. 11701360 - Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition (2023-07-18),

4. 11459311 - Pharmaceutical composition containing indirubin derivative as active ingredient (2022-10-04),

5. 11154566 - Composition for preventing hair loss or promoting hair growth (2021-10-26),

6. 11147816 - Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition (2021-10-19),

7. 10485802 - Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition (2019-11-26),

8. 10179132 - Composition for inducing differentiation of multipotent neural stem cells into dopaminergic neurons and method for inducing differentiation of multipotent neural stem cells into dopaminergic neurons by using the same (2019-01-15),

9. 10149833 - Small molecule, indirubin-3-oxime, for prevention and treatment of bone disease (2018-12-11),

10. 9763994 - Composition for promoting wound healing (2017-09-19),

11. 9150630 - Use of Idbf (2015-10-06),

12. 8952060 - Composition for preventing hair loss or for stimulating hair growth (2015-02-10),

Title: Innovations of Kang-Yell Choi

Introduction

Kang-Yell Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the development of therapeutic compositions for neurodegenerative diseases and wound healing. With a total of 12 patents to his name, Choi's work is recognized for its potential impact on healthcare.

Latest Patents

Choi's latest patents include groundbreaking compositions and methods aimed at suppressing and treating neurodegenerative diseases. One notable patent focuses on therapeutic compositions that inhibit the CXXC5-DVL interface and enhance the activity of GLP-1. These compositions are designed to model, treat, reduce resistance to treatment, prevent, and diagnose conditions associated with neurodegenerative diseases. Another significant patent involves a pharmaceutical composition for preventing or treating wounds, which includes an indirubin derivative as the active ingredient. This composition is effective in promoting wound healing and reducing scarring, particularly in diabetic conditions.

Career Highlights

Throughout his career, Kang-Yell Choi has worked with esteemed institutions such as Yonsei University and Ck Regeon Inc. His research has led to advancements in therapeutic methods that address critical health issues, showcasing his dedication to improving patient outcomes.

Collaborations

Choi has collaborated with notable colleagues, including Mi-Yeon Kim and Hyun-Yi Kim. These partnerships have contributed to the success of his innovative projects and the development of effective medical solutions.

Conclusion

Kang-Yell Choi's contributions to the field of medical science through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of neurodegenerative diseases and wound healing.

This text is generated by artificial intelligence and may not be accurate.